Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

Influencers see Nvidia’s $100 billion investment in OpenAI reshaping AI landscape, reveals GlobalData

OpenAI Inc. became a trending company among influencers on ‘X’ this week due to a significant strategic partnership with NVIDIA, involving an investment of up to $100 billion. The scale of this project, involving 10 gigawatts of NVIDIA systems and millions of GPUs, has captured the attention of influencers, highlighting the immense capital expenditure required […]
Read more

Anbenitamab to gain competitive edge as first bispecific mAb in HER-positive gastric cancer market in China, says GlobalData

China’s National Medical Products Administration (NMPA) has recently accepted the New Drug Application (NDA) of Alphamab Oncology’s KN026 (anbenitamab). If approved, KN026 is expected to become the first bispecific monoclonal antibody (mAb) targeting HER2-positive gastric or gastroesophageal (GEJ) carcinoma and evolve as a potential treatment option in the gastric cancer landscape in China, says GlobalData, […]
Read more

Verizon Business need to showcase advantages it holds over competitors, says GlobalData

In September 2025, Verizon Business held an ‘Innovation Session’ for enterprise, small business, and public sector customers, its fourth of six for the year. Although the event was valuable, Verizon Business could position itself more effectively at future events by placing greater emphasis on advantages the company holds over competitors, its customer support capabilities, and […]
Read more

Cadillac’s ad campaigns highlight performance, personalization, and eco-responsibility, reveals GlobalData

Cadillac’s YouTube advertising campaigns from June to August 2025 showcase a focus on electric luxury models, emphasizing innovation, sustainability, and premium experiences. From the sophisticated ESCALADE IQ to the bespoke CELESTIQ, Cadillac’s advertisements resonate with individuals who value technology and high-quality craftsmanship. By showcasing advanced driver assistance systems, customized design features, and eco-friendly performance, Cadillac […]
Read more

Johnson & Johnson to face fierce competition from Boston Scientific in US electrophysiology device market, says GlobalData

Johnson & Johnson and Boston Scientific are currently the companies with the largest market shares in the US electrophysiology devices market. Johnson & Johnson has held majority market share for over a decade. From Q4 2024 to present, Boston Scientific’s Farawave pulsed field ablation catheter has maintained its place as the highest revenue product line […]
Read more

APAC deal activity holds steady as M&A and select markets drive growth during January-August 2025, finds GlobalData

The Asia-Pacific (APAC) deal landscape (comprising mergers & acquisitions (M&A), private equity, and venture financing deals) exhibited modest expansion in the January-August 2025 period, underpinned by an increase in M&A activity and notable growth in some markets. Total deal volume across the region increased by around 1% during the first eight months of 2025 compared […]
Read more

FDA ends HAE drought with record approvals in 2025, reveals GlobalData

After four years of inactivity, the FDA approved three novel products for hereditary angioedema (HAE) in 2025. This bumper year increased the total number of marketed innovator drugs in the US to 11, introducing new mechanisms and modalities that broaden the treatment strategies available to patients, according to GlobalData, a leading data and analytics company. […]
Read more

Global deal activity down 3% YoY during January-August 2025, but some bright spots emerge, finds GlobalData

Global deal activity witnessed a year‑on‑year (YoY) decline during January-August 2025, with contractions across all deal types and most of the regions, even as pockets of resilience and growth emerged. The total number of deals (comprising mergers & acquisitions (M&A), private equity and venture financing deals) announced globally fell by around 3% during January-August 2025 […]
Read more

Influencers hail GPT-5 Codex as game-changer for adaptive reasoning and long-task execution, reveals GlobalData

OpenAI trended in the mid- September 2025, following the launch of GPT-5‑Codex, a GPT‑5 variant tuned for coding. It features extended autonomous operation (up to 7+ hours) and practical integrations, such as a VS Code extension and Codex CLI. Influencers hailed the model’s adaptive reasoning, which efficiently handles simple tasks with minimal tokens while dedicating […]
Read more

Pozelimab and cemdisiran combination holds potential to challenge existing complement inhibitors in MG market, says GlobalData

Regeneron recently announced exciting results from a Phase III clinical trial called NIMBLE, evaluating the efficacy and safety of pozelimab + cemdisiran combination therapy and cemdisiran monotherapy for adult patients living with generalized myasthenia gravis (gMG). The results showed that both cemdisiran monotherapy and pozelimab + cemdisiran combination therapy met their primary endpoints, displaying a […]
Read more

World Sepsis Day 2025: Improved awareness, faster diagnosis, and investment in novel therapeutics key to tackle huge healthcare burden, says GlobalData

World Sepsis Day, which takes place annually on September 13, aims to raise awareness and understanding of this life-threatening condition. World Sepsis Day 2025 also marks one year since the launch of the 2030 Global Agenda for Sepsis by the Global Sepsis Alliance. This strategy aims to reduce the global incidence of sepsis by at […]
Read more
1 … 28 29 30 31 32 … 136